These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The relationship between complaints of night-time heartburn and sleep-related gastroesophageal reflux. Orr WC; Goodrich S; Estep ME; Shepherd K Dis Esophagus; 2014; 27(4):303-10. PubMed ID: 24033500 [TBL] [Abstract][Full Text] [Related]
9. Relationships between sleep quality and pH monitoring findings in persons with gastroesophageal reflux disease. Dickman R; Green C; Fass SS; Quan SF; Dekel R; Risner-Adler S; Fass R J Clin Sleep Med; 2007 Aug; 3(5):505-13. PubMed ID: 17803014 [TBL] [Abstract][Full Text] [Related]
10. Heartburn and gastro-oesophageal reflux. Bennett JR Br J Clin Pract; 1991; 45(4):273-7. PubMed ID: 1810362 [TBL] [Abstract][Full Text] [Related]
11. Comparison of distribution of intraesophageal pH during nighttime recumbency among patients with gastroesophageal reflux disease. Hershcovici T; Jha LK; Fass R J Clin Gastroenterol; 2012 Aug; 46(7):562-6. PubMed ID: 22476040 [TBL] [Abstract][Full Text] [Related]
14. The relationship between gastro-oesophageal reflux symptoms and achalasia. Anderson SH; Yadegarfar G; Arastu MH; Anggiansah R; Anggiansah A Eur J Gastroenterol Hepatol; 2006 Apr; 18(4):369-74. PubMed ID: 16538107 [TBL] [Abstract][Full Text] [Related]
15. Comparisons of the distribution of oesophageal acid exposure throughout the sleep period among the different gastro-oesophageal reflux disease groups. Dickman R; Parthasarathy S; Malagon IB; Jones P; Han B; Powers J; Fass R Aliment Pharmacol Ther; 2007 Jul; 26(1):41-8. PubMed ID: 17555420 [TBL] [Abstract][Full Text] [Related]
16. Gastro-oesophageal reflux in patients with coronary artery disease: how common is it and does it matter? Mehta AJ; de Caestecker JS; Camm AJ; Northfield TC Eur J Gastroenterol Hepatol; 1996 Oct; 8(10):973-8. PubMed ID: 8930561 [TBL] [Abstract][Full Text] [Related]
17. Randomised clinical trial: effects of monotherapy with ADX10059, a mGluR5 inhibitor, on symptoms and reflux events in patients with gastro-oesophageal reflux disease. Zerbib F; Bruley des Varannes S; Roman S; Tutuian R; Galmiche JP; Mion F; Tack J; Malfertheiner P; Keywood C Aliment Pharmacol Ther; 2011 Apr; 33(8):911-21. PubMed ID: 21320138 [TBL] [Abstract][Full Text] [Related]
18. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy. Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422 [TBL] [Abstract][Full Text] [Related]
19. Effects of a single dose of rabeprazole 20 mg and pantoprazole 40 mg on 24-h intragastric acidity and oesophageal acid exposure: a randomized study in gastro-oesophageal reflux disease patients with a history of nocturnal heartburn. Miner P; Delemos B; Xiang J; Lococo J; Ieni J Aliment Pharmacol Ther; 2010 May; 31(9):991-1000. PubMed ID: 20132153 [TBL] [Abstract][Full Text] [Related]
20. Reflux monitoring: pH-metry, Bilitec and oesophageal impedance measurements. Pohl D; Tutuian R Best Pract Res Clin Gastroenterol; 2009; 23(3):299-311. PubMed ID: 19505660 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]